Famy Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.51 Cr
as on 17-07-2024
- Paid Up Capital ₹ 1.42 Cr
as on 17-07-2024
- Company Age 16 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 110.00 Cr
as on 17-07-2024
- Revenue 240.58%
(FY 2022)
- Profit 100.23%
(FY 2022)
- Ebitda -33.01%
(FY 2022)
- Net Worth 9.24%
(FY 2022)
- Total Assets 77.66%
(FY 2022)
About Famy Life Sciences
The Corporate was formerly known as Famy Energy Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.51 Cr and a paid-up capital of Rs 1.42 Cr.
The company has closed loans amounting to ₹110.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Famy Life Sciences Private Limited India is Siva Kuncham as COMPANY SECRETARY. Ajay Rathore and Rajeev Mukundan serve as directors at the Company.
- CIN/LLPIN
U40109GJ2008PTC109640
- Company No.
109640
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
27 Oct 2008
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Famy Life Sciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siva Kuncham  | Company Secretary | 04-Feb-2023 | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajeev Mukundan | Director | 10-Feb-2023 | Current |
| Ajay Rathore | Director | 10-Feb-2023 | Current |
Financial Performance and Corporate Structure Insights of Famy Life Sciences.
Famy Life Sciences Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 240.58% increase. The company also saw a substantial improvement in profitability, with a 100.23% increase in profit. The company's net worth moved up by a moderate rise of 9.24%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Famy Life Sciences?
In 2022, Famy Life Sciences had a promoter holding of 83.54% and a public holding of 16.47%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 14 Aug 2017 | ₹100.00 Cr | Satisfied |
Hdfc Bank Limited Creation Date: 03 Jan 2011 | ₹10.00 Cr | Satisfied |
How Many Employees Work at Famy Life Sciences?
Famy Life Sciences has a workforce of 8 employees as of Mar 27, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Famy Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Famy Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
